CTMX vs BIIB: Which Stock is Better?
Side-by-side comparison of CytomX Therapeutics Inc and Biogen Inc in 2026
CTMX
CytomX Therapeutics Inc
—
BIIB
Biogen Inc
$199.95
Key Metrics Comparison
| Metric | CTMX | BIIB | Winner |
|---|---|---|---|
| Market Cap | $653.11M | $29.33B | BIIB |
| P/E Ratio | N/A | 21.39 | BIIB |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze CTMX
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CTMX or BIIB a better investment?
Comparing CTMX and BIIB: CytomX Therapeutics Inc has a market cap of $653.11M while Biogen Inc has $29.33B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CTMX and BIIB?
CTMX (CytomX Therapeutics Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CTMX or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CTMX or BIIB?
Both CTMX and BIIB show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: CTMX or BIIB?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: CTMX or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $29.33B compared to $653.11M for CTMX.
Should I buy CTMX or BIIB in 2026?
Both CTMX and BIIB have investment merit. CTMX trades at $N/A while BIIB trades at $199.95. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CTMX and BIIB stock?
Key differences: Market Cap ($653.11M vs $29.33B), P/E Ratio (N/A vs 21.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy CTMX or BIIB in 2026?
The choice between CTMX and BIIB depends on your investment goals. BIIB shows higher revenue growth (0.0%). BIIB has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between CTMX and BIIB?
CTMX (CytomX Therapeutics Inc) has a market cap of $653.11M, while BIIB (Biogen Inc) has a market cap of $29.33B. BIIB is the larger company by market value.